122 related articles for article (PubMed ID: 35130541)
1. Association of Urine Albumin-Creatinine Ratio and Cystatin C-Based Estimated GFR with Outcomes in Patients with Ischemic Stroke.
Zhou Y; Wu Y; Pan Y; Li H; Yan H; Meng X; Lin J; Wang H; Matsushita K; Wang Y
Kidney Blood Press Res; 2022; 47(5):320-328. PubMed ID: 35130541
[TBL] [Abstract][Full Text] [Related]
2. Cystatin C-based estimated GFR and albuminuria are independently associated with all-cause and CVD mortality in Korean population: The Dong-gu Study.
Kim HY; Kweon SS; Lee YH; Ryu SY; Nam HS; Shin MH; Park KS; Choi SW
Maturitas; 2021 Jan; 143():178-183. PubMed ID: 33308626
[TBL] [Abstract][Full Text] [Related]
3. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.
Peralta CA; Shlipak MG; Judd S; Cushman M; McClellan W; Zakai NA; Safford MM; Zhang X; Muntner P; Warnock D
JAMA; 2011 Apr; 305(15):1545-52. PubMed ID: 21482744
[TBL] [Abstract][Full Text] [Related]
4. Estimated glomerular filtration rate and urine biomarkers in patients with single-ventricle Fontan circulation.
Opotowsky AR; Baraona FR; Mc Causland FR; Loukas B; Landzberg E; Landzberg MJ; Sabbisetti V; Waikar SS
Heart; 2017 Mar; 103(6):434-442. PubMed ID: 27670967
[TBL] [Abstract][Full Text] [Related]
5. Impact of Kidney Function on Cardiovascular Risk and Mortality: A Comparison of South Asian and European Cohorts.
Eastwood SV; Chaturvedi N; Sattar N; Welsh PI; Hughes AD; Tillin T
Am J Nephrol; 2019; 50(6):425-433. PubMed ID: 31665726
[TBL] [Abstract][Full Text] [Related]
6. Frailty, Kidney Function, and Polypharmacy: The Atherosclerosis Risk in Communities (ARIC) Study.
Ballew SH; Chen Y; Daya NR; Godino JG; Windham BG; McAdams-DeMarco M; Coresh J; Selvin E; Grams ME
Am J Kidney Dis; 2017 Feb; 69(2):228-236. PubMed ID: 27884475
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Cystatin C Level for Risk Stratification in Adults With Chronic Kidney Disease.
Lees JS; Rutherford E; Stevens KI; Chen DC; Scherzer R; Estrella MM; Sullivan MK; Ebert N; Mark PB; Shlipak MG
JAMA Netw Open; 2022 Oct; 5(10):e2238300. PubMed ID: 36282503
[TBL] [Abstract][Full Text] [Related]
8. Marijuana Use and Estimated Glomerular Filtration Rate in Young Adults.
Ishida JH; Auer R; Vittinghoff E; Pletcher MJ; Reis JP; Sidney S; Johansen KL; Bibbins-Domingo K; Peralta CA; Shlipak MG
Clin J Am Soc Nephrol; 2017 Oct; 12(10):1578-1587. PubMed ID: 28838990
[TBL] [Abstract][Full Text] [Related]
9. Differential Associations of Cystatin C Versus Creatinine-Based Kidney Function With Risks of Cardiovascular Event and Mortality Among South Asian Individuals in the UK Biobank.
Chen DC; Lees JS; Lu K; Scherzer R; Rutherford E; Mark PB; Kanaya AM; Shlipak MG; Estrella MM
J Am Heart Assoc; 2023 Feb; 12(3):e027079. PubMed ID: 36695320
[TBL] [Abstract][Full Text] [Related]
10. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
Kühn A; van der Giet M; Kuhlmann MK; Martus P; Mielke N; Ebert N; Schaeffner ES
Am J Kidney Dis; 2021 Mar; 77(3):386-396.e1. PubMed ID: 33197533
[TBL] [Abstract][Full Text] [Related]
11. Cystatin C, albuminuria, and mortality among older adults with diabetes.
de Boer IH; Katz R; Cao JJ; Fried LF; Kestenbaum B; Mukamal K; Rifkin DE; Sarnak MJ; Shlipak MG; Siscovick DS
Diabetes Care; 2009 Oct; 32(10):1833-8. PubMed ID: 19587367
[TBL] [Abstract][Full Text] [Related]
12. Association of kidney disease measures with ischemic versus hemorrhagic strokes: pooled analyses of 4 prospective community-based cohorts.
Mahmoodi BK; Yatsuya H; Matsushita K; Sang Y; Gottesman RF; Astor BC; Woodward M; Longstreth WT; Psaty BM; Shlipak MG; Folsom AR; Gansevoort RT; Coresh J
Stroke; 2014 Jul; 45(7):1925-31. PubMed ID: 24876078
[TBL] [Abstract][Full Text] [Related]
13. Discordances Between Creatinine- and Cystatin C-Based Estimated GFR and Adverse Clinical Outcomes in Routine Clinical Practice.
Carrero JJ; Fu EL; Sang Y; Ballew S; Evans M; Elinder CG; Barany P; Inker LA; Levey AS; Coresh J; Grams ME
Am J Kidney Dis; 2023 Nov; 82(5):534-542. PubMed ID: 37354936
[TBL] [Abstract][Full Text] [Related]
14. Albuminuria as a Predictor of Cardiovascular Outcomes in Patients With Acute Myocardial Infarction.
Mok Y; Ballew SH; Sang Y; Grams ME; Coresh J; Evans M; Barany P; Ärnlöv J; Carrero JJ; Matsushita K
J Am Heart Assoc; 2019 Apr; 8(8):e010546. PubMed ID: 30947615
[TBL] [Abstract][Full Text] [Related]
15. Combined association of albuminuria and cystatin C-based estimated GFR with mortality, coronary heart disease, and heart failure outcomes: the Atherosclerosis Risk in Communities (ARIC) Study.
Waheed S; Matsushita K; Sang Y; Hoogeveen R; Ballantyne C; Coresh J; Astor BC
Am J Kidney Dis; 2012 Aug; 60(2):207-16. PubMed ID: 22537422
[TBL] [Abstract][Full Text] [Related]
16. Creatinine- and cystatin C-based estimated glomerular filtration rate slopes for the prediction of kidney outcome: a comparative retrospective study.
Kim S; Hwang S; Jang HR; Sohn I; Ahn HS; Park HD; Huh W; Jin DC; Kim YG; Kim DJ; Oh HY; Lee JE
BMC Nephrol; 2019 Jun; 20(1):214. PubMed ID: 31185945
[TBL] [Abstract][Full Text] [Related]
17. Sex differences in associations between creatinine and cystatin C-based kidney function measures with stroke and major bleeding.
Lees JS; De La Mata NL; Sullivan MK; Wyld ML; Rosales BM; Cutting R; Hedley JA; Rutherford E; Mark PB; Webster AC
Eur Stroke J; 2023 Sep; 8(3):756-768. PubMed ID: 37641551
[TBL] [Abstract][Full Text] [Related]
18. Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes.
Jeon YK; Kim MR; Huh JE; Mok JY; Song SH; Kim SS; Kim BH; Lee SH; Kim YK; Kim IJ
J Korean Med Sci; 2011 Feb; 26(2):258-63. PubMed ID: 21286018
[TBL] [Abstract][Full Text] [Related]
19. Combined association of creatinine, albuminuria, and cystatin C with all-cause mortality and cardiovascular and kidney outcomes.
Waheed S; Matsushita K; Astor BC; Hoogeveen RC; Ballantyne C; Coresh J
Clin J Am Soc Nephrol; 2013 Mar; 8(3):434-42. PubMed ID: 23258794
[TBL] [Abstract][Full Text] [Related]
20. The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
Potok OA; Ix JH; Shlipak MG; Katz R; Hawfield AT; Rocco MV; Ambrosius WT; Cho ME; Pajewski NM; Rastogi A; Rifkin DE
Am J Kidney Dis; 2020 Dec; 76(6):765-774. PubMed ID: 32682697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
